2025-02-012026-01-312026-01-31false14592661Cammed Therapeutics Ltd2026-08-2772110falseiso4217:GBPxbrli:pure145926612025-01-31145926612026-01-31145926612025-02-012026-01-31145926612024-01-31145926612025-01-31145926612024-02-012025-01-3114592661bus:Micro-entities2025-02-012026-01-3114592661bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3114592661bus:FullAccounts2025-02-012026-01-3114592661bus:PrivateLimitedCompanyLtd2025-02-012026-01-3114592661core:WithinOneYear2026-01-3114592661core:AfterOneYear2026-01-3114592661core:WithinOneYear2025-01-3114592661core:AfterOneYear2025-01-311459266112025-02-012026-01-3114592661dpl:CostSales2025-02-012026-01-3114592661dpl:AdministrativeExpenses2025-02-012026-01-3114592661dpl:DistributionCosts2025-02-012026-01-3114592661dpl:CostSales2024-02-012025-01-3114592661dpl:AdministrativeExpenses2024-02-012025-01-3114592661dpl:DistributionCosts2024-02-012025-01-3114592661core:WithinOneYear2026-01-3114592661core:AfterOneYear2026-01-3114592661core:WithinOneYear2025-01-3114592661core:AfterOneYear2025-01-3114592661core:WithinOneYear2025-02-012026-01-3114592661core:AfterOneYear2025-02-012026-01-3114592661bus:Director12025-02-012026-01-3114592661bus:Director22025-02-012026-01-3114592661bus:Director32025-02-012026-01-31

Cammed Therapeutics Ltd

(formerly CAMBRIDGE MEDIXINE LTD)

Registered Number
14592661
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

Cammed Therapeutics Ltd
Company Information
for the year from 1 February 2025 to 31 January 2026

Directors

BERKYUREK, Ahmet Can, Dr.
FANTACCINI, Simone, Dr.
SIMMEN, Kenneth Alan, Dr.

Registered Address

62 Skimmer Chase
Soham
Ely
CB7 6AW

Registered Number

14592661 (England and Wales)
Cammed Therapeutics Ltd
Statement of Financial Position
31 January 2026

2026
£

2025
£

Assets
Current Assets22,80794,879
22,80794,879
Capital, Reserves and Liabilities
Capital and reserves(161,226)(42,470)
Creditors amounts falling due within one year1,6484,027
Creditors amounts falling due after one year182,385133,322
22,80794,879
The financial statements were approved and authorised for issue by the Board of Directors on 27 August 2026, and are signed on its behalf by:
BERKYUREK, Ahmet Can, Dr.
Director
Registered Company No. 14592661